Skip to main content
¿Necesita servicios de traducción?
Comuníquese con nuestra mesa de ayuda 24/7/365 al 877-635-9545.

First Naloxone Product Approved for Use Without a Prescription

On March 29, 2023, the Food and Drug Administration approved the first naloxone product available without a prescription. Naloxone is a medication that rapidly reverses the effects of and is the standard treatment for opioid overdose. Emergent BioSolutions anticipates its Narcan (naloxone hydrochloride) 4 mg nasal spray will be available for consumers to purchase over-the-counter by August 2023. Pricing information has not yet been released. Currently, prescription versions will remain available through pharmacies (via standing order or co-prescription laws) and other community distribution methods.
For more information visit: https://www.fda.gov/news-events/press-announcements/fda-approves-first-over-counter-naloxone-nasal-spray

Photo Credit: Giovanni Cancemi - http://stock.adobe.com

First Naloxone Product Approved for Use Without a Prescription hero image
ProAct Logo ProAct Logo ProAct Logo
mobile image tablet image desktop image